CardioNet (NASDAQ:BEAT), just renamed BioTelemetry, soared by 38% on a day a couple weeks ago, taking this tiny company to a market capitalization of approximately $192 million by the close of trading. The huge gain came on extraordinary volume of 8.99 million shares traded, versus the 3-month average of 730K. Obviously, there was a catalyst, and it was the best possible of all drivers that moved the shares. CardioNet reported its second quarter earnings after the close of trading the day before, and I think it's safe to say the news was well received. We take a closer look at the results and the company herein. After seven years of following small-cap stocks as a senior analyst on...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|